ID

44020

Description

Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00049998

Link

https://clinicaltrials.gov/show/NCT00049998

Keywords

Versions (2)
  1. 5/25/16 5/25/16 -
  2. 9/20/21 9/20/21 -
Uploaded on

September 20, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Non-Small-Cell Lung Cancer NCT00049998

English

Eligibility Non-Small-Cell Lung Cancer NCT00049998

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
written informed consent
Description

written informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
patients with advanced non-small cell lung cancer (nsclc).
Description

nsclc

Data type

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205179
patients who have received one previous chemotherapy for nsclc.
Description

previous chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0392920
full recovery from previous chemotherapy.
Description

full recovery from previous chemotherapy

Data type

boolean

Alias
UMLS CUI [1,1]
C2004454
UMLS CUI [1,2]
C0392920
presence of either measurable or non-measurable disease by radiologic study or physical examination.
Description

comorbidity

Data type

boolean

Alias
UMLS CUI [1]
C0009488
at least 3 weeks since last major surgery (a lesser period is acceptable if deemed in the best interest of the patient).
Description

major surgery

Data type

boolean

Alias
UMLS CUI [1]
C0679637
at least 24 hours since prior radiotherapy providing that marked bone marrow suppression is not expected. patients who have received radiotherapy must have recovered from any reversible side effects (e.g. nausea and vomiting).
Description

recovered from any reversible side effects

Data type

boolean

Alias
UMLS CUI [1,1]
C2826210
UMLS CUI [1,2]
C0001688
UMLS CUI [1,3]
C1522449
laboratory criteria: patients must have adequate bone marrow reserve and adequate kidney and liver function.
Description

adequate bone marrow reserve and adequate kidney and liver function

Data type

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0205411
UMLS CUI [2,1]
C0232804
UMLS CUI [2,2]
C0205411
UMLS CUI [3,1]
C0232741
UMLS CUI [3,2]
C0205411
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
symptoms of brain metastasis (cancer spreading to the brain), requiring treatment with steroids.
Description

brain metastasis

Data type

boolean

Alias
UMLS CUI [1]
C0220650
active infection.
Description

active infection

Data type

boolean

Alias
UMLS CUI [1]
C0009450
severe medical problems other than the diagnosis of nsclc, that would limit the ability of the patient to follow study guidelines or expose the patient to extreme risk.
Description

comorbidity limiting study participation

Data type

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
ongoing or planned chemotherapy, immunotherapy, radiotherapy, or investigational therapy for the treatment of nsclc.
Description

planned therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C1301732
use of investigational drug within 30 days prior to the first dose of study medication.
Description

participation in another trial

Data type

boolean

Alias
UMLS CUI [1]
C2348568
women who are pregnant or lactating.
Description

pregnant or lactating women

Data type

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
patients of child-bearing potential refusing to practice adequate birth control methods.
Description

contraceptive use

Data type

boolean

Alias
UMLS CUI [1]
C1999124
patients with conditions which might alter absorption of an oral drug.
Description

conditions which might alter absorption

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0000854
Back to the top of the page

Similar models

Eligibility Non-Small-Cell Lung Cancer NCT00049998

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
written informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
nsclc
Item
patients with advanced non-small cell lung cancer (nsclc).
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
previous chemotherapy
Item
patients who have received one previous chemotherapy for nsclc.
boolean
C0392920 (UMLS CUI [1])
full recovery from previous chemotherapy
Item
full recovery from previous chemotherapy.
boolean
C2004454 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
comorbidity
Item
presence of either measurable or non-measurable disease by radiologic study or physical examination.
boolean
C0009488 (UMLS CUI [1])
major surgery
Item
at least 3 weeks since last major surgery (a lesser period is acceptable if deemed in the best interest of the patient).
boolean
C0679637 (UMLS CUI [1])
recovered from any reversible side effects
Item
at least 24 hours since prior radiotherapy providing that marked bone marrow suppression is not expected. patients who have received radiotherapy must have recovered from any reversible side effects (e.g. nausea and vomiting).
boolean
C2826210 (UMLS CUI [1,1])
C0001688 (UMLS CUI [1,2])
C1522449 (UMLS CUI [1,3])
adequate bone marrow reserve and adequate kidney and liver function
Item
laboratory criteria: patients must have adequate bone marrow reserve and adequate kidney and liver function.
boolean
C0005953 (UMLS CUI [1,1])
C0205411 (UMLS CUI [1,2])
C0232804 (UMLS CUI [2,1])
C0205411 (UMLS CUI [2,2])
C0232741 (UMLS CUI [3,1])
C0205411 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
brain metastasis
Item
symptoms of brain metastasis (cancer spreading to the brain), requiring treatment with steroids.
boolean
C0220650 (UMLS CUI [1])
active infection
Item
active infection.
boolean
C0009450 (UMLS CUI [1])
comorbidity limiting study participation
Item
severe medical problems other than the diagnosis of nsclc, that would limit the ability of the patient to follow study guidelines or expose the patient to extreme risk.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
planned therapy
Item
ongoing or planned chemotherapy, immunotherapy, radiotherapy, or investigational therapy for the treatment of nsclc.
boolean
C0087111 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
participation in another trial
Item
use of investigational drug within 30 days prior to the first dose of study medication.
boolean
C2348568 (UMLS CUI [1])
pregnant or lactating women
Item
women who are pregnant or lactating.
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
contraceptive use
Item
patients of child-bearing potential refusing to practice adequate birth control methods.
boolean
C1999124 (UMLS CUI [1])
conditions which might alter absorption
Item
patients with conditions which might alter absorption of an oral drug.
boolean
C0087111 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0000854 (UMLS CUI [1,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial